Impact of UGT1A1 polymorphisms on Raltegravir and its glucuronide plasma concentrations in a cohort of HIV-1 infected patients
Abstract The aim of this study was to evaluate the effect of UGT1A1 polymorphisms on Raltegravir (RAL) and its metabolite RAL-glucuronide trough plasma concentrations ([RAL]plasma and [RAL-glu]plasma) and on the metabolic ratio (MR): [RAL-glu]plasma/[RAL]plasma. UGT1A1 genotyping was performed on 96...
Guardado en:
Autores principales: | Leïla Belkhir, Carole Seguin-Devaux, Laure Elens, Caroline Pauly, Nicolas Gengler, Serge Schneider, Jean Ruelle, Vincent Haufroid, Bernard Vandercam |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2018
|
Materias: | |
Acceso en línea: | https://doaj.org/article/c11be330a5f74880b09545120987b42d |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
The effect of UGT1A1 promoter polymorphism in the development of hyperbilirubinemia and cholelithiasis in hemoglobinopathy patients.
por: Suad AlFadhli, et al.
Publicado: (2013) -
Role of raltegravir in the management of HIV-1 infection
por: Okeke NL, et al.
Publicado: (2011) -
Effect of four ABCB1 genetic polymorphisms on the accumulation of darunavir in HEK293 recombinant cell lines
por: Gabriel Stillemans, et al.
Publicado: (2021) -
Body fat percentage is a major determinant of total bilirubin independently of UGT1A1*28 polymorphism in young obese.
por: Luís Belo, et al.
Publicado: (2014) -
The importance of the UGT1A1 variants in the development of osteopenia and osteoporosis in postmenopausal women
por: Anna Bogacz, et al.
Publicado: (2021)